5/5 - (1 vote)

MedVi vs Hone: Compare GLP-1 Programs & Pricing

Side-by-side MedVi and Hone: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

MedVi and Hone are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares MedVi vs Hone to help you identify which best fits your goals, budget, and preferences.

Visit MedVi
Explore Hone

MedVi vs Hone: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
MedVi	$179.00	$279.00	$120 off first month (Code: )	— No
Hone				—

MedVi vs Hone: Medical Process & Accessibility

MedVi emphasizes a streamlined telehealth intake: patients complete an online health questionnaire, upload relevant labs, and receive clinician approval within 24‑48 hours. Once approved, a licensed U.S. pharmacy compounds the GLP‑1 medication and ships it directly to the patient’s door. Hone follows a similar virtual pathway but adds a mandatory video consultation, a structured 12‑week titration schedule, and routine virtual check‑ins to monitor response and safety.

Start with MedVi

MedVi vs Hone: Pricing Comparison

MedVi starts semaglutide at $179.00 and tirzepatide at $279.00. Because these are the only publicly disclosed starting prices, they represent the lower‑cost option for each medication. Hone does not list explicit pricing on its public site, so potential patients should request a personalized quote during the intake process.

Both providers may offer introductory discounts. MedVi currently promotes “$120 off the first month” (no promo code required). Hone has not published a comparable promotion at this time. Because MedVi does not require a membership fee, the listed price is the total cost for the first month, whereas Hone may incorporate a subscription‑style fee that could affect the overall expense.

Compare Hone Pricing

MedVi vs Hone: Clinical Oversight & Support

Both platforms employ board‑certified endocrinologists, obesity specialists, or nurse practitioners to review medical histories, evaluate contraindications, and prescribe the appropriate GLP‑1. MedVi’s model is built for rapid approval, making it attractive to patients who want to begin treatment quickly. Hone, on the other hand, integrates a longer‑term care plan, offering bi‑weekly virtual visits during the titration phase and monthly maintenance check‑ins thereafter.

Book a Consultation with MedVi

MedVi vs Hone: Medication Quality & Safety

Both companies use FDA‑registered compounding pharmacies that follow Good Manufacturing Practices (GMP). While the compounds are not the brand‑name products Wegovy® (semaglutide) or Mounjaro® (tirzepatide), they contain the same active ingredient and are prescribed under a clinician’s authority, satisfying FDA telehealth regulations for compounded medications.

MedVi vs Hone: Customer Experience

Customer reviews highlight MedVi’s affordability, quick shipping (often within 5‑7 business days), and a simple mobile app for order tracking. Patients appreciate the lack of a mandatory membership and the transparent $120 first‑month discount. Hone’s reviewers frequently mention the thoroughness of the clinical team, the personalized dose‑adjustment guidance, and the educational resources available through their patient portal. Shipping times are comparable, though some users note a slightly longer onboarding window due to the required video visit.

Explore Hone Reviews

MedVi vs Hone: Insurance & Billing

Neither MedVi nor Hone currently accept traditional health‑insurance plans for GLP‑1 therapy, as most insurers consider these medications investigational for weight loss. Both providers operate on a cash‑pay model, which simplifies billing and avoids prior‑authorization delays. Patients should verify whether their Flexible Spending Account (FSA) or Health Savings Account (HSA) can be used for out‑of‑pocket expenses.

MedVi vs Hone: Regulatory Compliance

Both services adhere to the Telemedicine Practice Guidelines set forth by the U.S. Department of Health & Human Services and maintain HIPAA‑compliant platforms for patient communication. Prescriptions are issued by clinicians licensed in the patient’s state of residence, ensuring state‑by‑state compliance. The compounded products are manufactured in FDA‑registered facilities, meeting all federal safety standards for telehealth‑prescribed medications.

MedVi vs Hone: Final Verdict

If you prioritize a low‑cost entry point, rapid onboarding, and a straightforward cash‑pay structure, MedVi is the clear choice. Its $179.00 semaglutide start price and $120 first‑month discount make it one of the most affordable GLP‑1 options on the market.

If you value ongoing clinical mentorship, a structured titration schedule, and a robust patient‑education platform, Hone may better suit your needs—even though exact pricing is not disclosed publicly.

Both providers are reputable, licensed telehealth companies that enable safe, physician‑guided access to GLP‑1 therapies across the United States.

Join MedVi
Get Started with Hone

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice